Dr. Reddy's Laboratories Limited (RDY) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Dr. Reddy's Laboratories ...

    NYSE: RDY · Real-Time Price · USD
    14.35
    0.20 (1.41%)
    At close: Sep 05, 2025, 3:59 PM
    14.35
    0.03%
    After-hours: Sep 05, 2025, 07:10 PM EDT

    Dr. Reddy's Laboratories Income Statement

    Financials in INR. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
    Revenue
    		 325.54B 279.16B 245.88B 214.39B 189.72B
    Cost of Revenue
    		 135.11B 115.56B 42.91B 100.55B 86.64B
    Gross Profit
    		 190.43B 163.61B 202.97B 113.84B 103.08B
    Operating Income
    		 71.84B 67.73B 96.28B 40.82B 36.06B
    Interest Income
    		 2.68B 2.28B 1.18B 965M 826M
    Pretax Income
    		 76.78B 71.87B 60.48B 32.3B 28.32B
    Net Income
    		 56.54B 55.68B 45.07B 23.57B 17.24B
    Selling & General & Admin
    		 93.87B 77.2B 105.93B 62.08B 54.56B
    Research & Development
    		 27.38B 22.87B 19.38B 17.48B 16.54B
    Other Expenses
    		 -2.67B -4.2B -7.7B -2.76B -982M
    Operating Expenses
    		 118.58B 95.88B 117.61B 76.8B 70.12B
    Interest Expense
    		 2.83B 1.71B 1.43B 958M 970M
    Selling & Marketing Expenses
    		 n/a n/a 59.47B n/a n/a
    Cost & Expenses
    		 253.69B 211.44B 160.52B 177.35B 156.76B
    Income Tax Expense
    		 19.54B 16.19B 15.41B 8.73B 9.18B
    Shares Outstanding (Basic)
    		 833.31M 833.54M 830.17M 829.41M 829.22M
    Shares Outstanding (Diluted)
    		 834.3M 833.54M 831.91M 831.69M 831.58M
    EPS (Basic)
    		 67.85 66.80 54.29 28.42 20.79
    EPS (Diluted)
    		 67.77 66.80 54.17 28.34 20.73
    EBITDA
    		 96.67B 88.42B 74.43B 47.74B 45.71B
    EBIT
    		 79.61B 73.58B 61.8B 33.26B 27.38B
    Depreciation & Amortization
    		 17.06B 14.84B 12.64B 11.82B 12.8B

    Add to Watchlist